Merete Haedersdal: Clinical Trials

13 trials sponsored by Merete Haedersdal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 recruiting, 1 active not recruiting, 1 terminated. 4 Not applicable, 4 Phase 2, 4 Phase 4, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Recruiting 1
Phase 24Completed 3, Active not recruiting 1
Phase 44Completed 3, Terminated 1
Phase 12Completed 2

Follow Merete Haedersdal: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multimodal Laser Treatment of Photodamaged Skin
1927-nm thulium laser, 1550-nm Er:Glass laser, Intense Pulsed Light - Photo-damage, Actinic Keratosis (AK)
Not applicableRecruitingMerete Haedersdal352026-09-012026-09-09
Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis
Cream containing madecassoside and 5 % panthenol, Daylight PDT - Actinic Keratoses
Not applicableCompletedMerete Haedersdal202023-09-272024-05-08
Treatment of Striae Distensae With Fractional Radiofrequency and Topical Tretinoin
Fractional radiofrequency and topical Tretinoin, Topical Tretinoin, Fractional radiofrequency - Striae Distensae
Phase 2CompletedMerete Haedersdal202022-11-222023-08-14
Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis
HPV Vaccine, PLACEBO vaccine - Actinic Keratoses, Basal Cell Carcinoma
Phase 2Active not recruitingMerete Haedersdal702022-05-092025-01-22
The Organ Transplant Recipient HPV and Skin Cancer Study
No intervention - Solid Organ Transplant Recipient, Skin Cancer
RecruitingMerete Haedersdal15002022-03-102025-04-01
Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis
Microwave thermolysis, Botulinum toxin A - Hyperhidrosis Primary Focal Axilla
Phase 4CompletedMerete Haedersdal302021-09-272023-05-26
TMFI Enhances Skin Surface and Epidermal PpIX Fluorescence
TMFI, ALA cream, ALA gel - Normal Skin
Phase 4CompletedMerete Haedersdal162019-04-292020-01-09
Treatment of Photodamaged Skin of the décolleté
Photodynamic therapy, Non-ablative Thulium laser (NAFL), Radio-frequency microneedles (RF-MN) - Photodamaged Skin
Phase 4TerminatedMerete Haedersdal122018-09-102020-07-10
Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study
AFL-assisted cisplatin+5-FU - Carcinoma, Basal Cell
Phase 1 / Phase 2CompletedMerete Haedersdal202018-03-092022-04-14
Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery
Adapalene-Benzoyl Peroxide Gel 0.1-2.5% - Acne Vulgaris, Microparticles
Not applicableCompletedMerete Haedersdal162018-01-042022-03-21
Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate
AFXl-assisted ingenol mebutate delivery - Carcinoma, Basal Cell
Phase 1 / Phase 2CompletedMerete Haedersdal202017-11-172018-07-10
Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography
SEB-250 - Acne Vulgaris
Not applicableCompletedMerete Haedersdal212016-12-012018-05-14
Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias
Brimonidine, IPL+air-cooling - Telangiectasias
Phase 4CompletedMerete Haedersdal192016-03-132018-01-05

Conditions studied

Carcinoma, Basal Cell (3)  ·  Keratosis, Actinic (3)  ·  Acne Vulgaris (2)  ·  Carcinoma, Squamous Cell (1)  ·  Inflammation (1)  ·  Papillomavirus Infections (1)  ·  Skin Neoplasms (1)  ·  Striae Distensae (1)  ·  Telangiectasis (1)  ·  Uterine Cervical Dysplasia (1)  ·  Uterine Cervical Neoplasms (1)

Interventions

Botulinum Toxins, Type A (1)  ·  Brimonidine Tartrate (1)  ·  Intense Pulsed Light Therapy (1)  ·  Papillomavirus Vaccines (1)  ·  Photochemotherapy (1)  ·  Tretinoin (1)  ·  dexpanthenol (1)

Countries

Denmark (13)

Top investigators

Emily Wenande, MD, PhD (1)

Results publications

PMID 40047786, PMID 42533163

NIH funding

2018 (2), 2015 (1)